This has led to the creation of GLP-1 agonists and analogues capable of effectively activating all receptor and cellular systems compatible with GLP-1
In the U.S., post-market surveillance data from 20052023 show over 6,700 cases of pancreatitis tied to GLP-1 drugs, leading to growing concern among healthcare providers and attorneys
annually causes significant RAF loss for MA plans (~0.519 per patient per year)
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study
Final Thoughts GLP-1 drugs like Ozempic and Wegovy are powerful tools for weight loss and diabetes managementbut they are not risk-free
By stabilizing blood glucose levels, GLP-1 receptor agonists may reduce glucose-related cognitive fluctuations